CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis
Authors
A Cortes
A Cortes
+32Â more
A Keat
AL Taylor
Amity Roberts
AP Gregory
Carla Cohen
D Ellinghaus
E Roussou
EM Mowry
G Bakland
HT Idriss
J Freeston
JD Castillo-Ortiz
L Ottoboni
Laura Watts
LJ Maxwell
Louise Appleton
M Comabella
M Corbett
M Rudwaleit
MA Brown
Matteo Vecellio
N Akkoc
Paul Wordsworth
S Linden Van der
S Sawcer
SI Davidson
T Karaderi
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
Tom Wordsworth
Tugce Karaderi
W Chen
Z Zeng
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1038%2Fs41435-018-...
Last time updated on 11/12/2019